Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Elsulfavirine/emtricitabine/tenofovir - Viriom

Next Previous
Search
Drug Profile

Elsulfavirine/emtricitabine/tenofovir - Viriom

Alternative Names: Agape; Agape® FDC - Viriom; ESV/FTC/TDF - Viriom; VM 1500FDC

Latest Information Update: 21 Jun 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Viriom
  • Class Acetamides; Adenine nucleotides; Antiretrovirals; Deoxyribonucleosides; Nitriles; Phosphonic acids; Purines; Pyrimidine nucleosides; Small molecules; Sulfones
  • Mechanism of Action DNA polymerase beta inhibitors; DNA polymerase gamma inhibitors; DNA polymerase I inhibitors; DNA polymerase II inhibitors; HIV reverse transcriptase inhibitors; Non-nucleoside reverse transcriptase inhibitors; Nucleotide reverse transcriptase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered HIV-1 infections

Most Recent Events

  • 21 Jun 2022 Registered for HIV-1 infections in Russia, Kazakhstan, Kyrgyzstan, Belarus, Armenia (PO) in 2022 (Viriom pipeline, June 2022)
  • 02 Feb 2021 Preregistration for HIV-1 infections in Kazakhstan, Kyrgyzstan, Belarus, Russia, Armenia (PO)
  • 02 Jul 2019 Viriom enters into a licensing agreement with Lloyds Pharma for elsulfavirine and other drugs from Viriom HIV and Hepatitis B portfolio in Indonesia

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top